Search results
Jump to navigation
Jump to search
Google site results
Loading...
Wiki results
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:19, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:28, 13 December 2023
- {{DISPLAYTITLE:Subcutaneous panniculitis-like T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:40, 13 December 2023
- {{DISPLAYTITLE:Indolent T-lymphoblastic proliferation}} ==Cancer Category / Type==11 KB (1,512 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,512 words) - 14:24, 13 December 2023
- {{DISPLAYTITLE:Extranodal NK/T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,515 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:27, 13 December 2023
- {{DISPLAYTITLE:Peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,515 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,515 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,520 words) - 11:21, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:39, 13 December 2023
- {{DISPLAYTITLE:T-lymphoblastic leukaemia / lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 15:52, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,517 words) - 15:33, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,533 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,518 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:34, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous gamma/delta T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,521 words) - 14:38, 13 December 2023
- {{DISPLAYTITLE:T-cell/histiocyte-rich large B-cell lymphoma}} ==Cancer Category / Type==11 KB (1,518 words) - 14:41, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,521 words) - 14:36, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,529 words) - 15:31, 22 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,524 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==13 KB (1,759 words) - 14:19, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder}} ==Cancer Category / Type==11 KB (1,527 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,530 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,527 words) - 14:38, 13 December 2023
- ...AYTITLE:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma}} ==Cancer Category / Type==11 KB (1,530 words) - 14:37, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis}} ==Cancer Category / Type==11 KB (1,530 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,536 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,539 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,545 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,556 words) - 14:28, 13 December 2023
- ==Cancer Category/Type== ...substitution mutations, is found at a low level in many cancers ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=etv6 see COSMIC]); it is more prominen9 KB (1,371 words) - 14:18, 12 December 2023
- ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome12 KB (1,749 words) - 13:50, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,601 words) - 15:20, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==11 KB (1,576 words) - 14:40, 6 March 2024
- {{DISPLAYTITLE:Intestinal T-cell lymphoma, NOS}} ...mplate on 2023-12-07. The original page can be found at [[HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]].13 KB (1,756 words) - 14:28, 13 December 2023
- '''Cancer Category/Type''' '''Cancer Sub-Classification/Subtype'''7 KB (872 words) - 15:02, 12 December 2023
- ==Cancer Category/Type== Nearly universal involvement in diverse cancer types.11 KB (1,625 words) - 18:14, 5 January 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (2,002 words) - 14:18, 13 December 2023
- Hui Chen, MD, PhD, The University of Texas MD Anderson Cancer Center ==Cancer Category/Type==9 KB (1,336 words) - 16:42, 16 April 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,992 words) - 14:26, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]. Cancer Category/Type14 KB (1,917 words) - 14:20, 13 December 2023
- [[File:T(6;9)(p23;q34).png]] ==Cancer Category/Type==10 KB (1,452 words) - 10:55, 12 September 2022
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,064 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,127 words) - 14:23, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]. ==Cancer Category / Type==12 KB (1,796 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,146 words) - 12:07, 23 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,256 words) - 14:31, 13 December 2023
- ...ssue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). <nowiki>htt !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence13 KB (1,889 words) - 14:19, 14 March 2024
- Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to .... The CCGA is interested in the curation of genes/mutations that arise in cancer. However, the dividing line between "Gene/Protein/Mutation" information an23 KB (3,717 words) - 14:25, 12 December 2023
- T. Niroshi Senaratne, UCLA ==Cancer Category / Type==16 KB (2,266 words) - 14:39, 13 December 2023
- ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome12 KB (1,695 words) - 13:43, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,323 words) - 14:34, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==18 KB (2,507 words) - 15:34, 20 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==15 KB (2,139 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,944 words) - 14:29, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,084 words) - 14:18, 13 December 2023
- ...>Diaz JI, Mora LB, Hakam A. The Mainz Classification of Renal Cell Tumors. Cancer Control. 1999 Nov;6(6):571-579</ref> ...ton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>3 KB (421 words) - 11:29, 22 August 2016
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==9 KB (1,329 words) - 15:49, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,153 words) - 14:35, 13 December 2023
- ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1]]. ==Cancer Category / Type==17 KB (2,425 words) - 14:21, 13 December 2023
- ...stic large cell lymphoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated 12/13/2023, <nowiki>https://ccga.io/inde ...ccur.<ref>Karikari, I.O.; Thomas, K.K.; Lagoo, A.; Cummings, T.J.; George, T.M. Primary Cerebral ALK-1-Positive Anaplastic Large Cell Lymphoma in a Chil10 KB (1,484 words) - 22:04, 27 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,020 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== Mature T-cell neoplasm / Cutaneous T-cell lymphoma19 KB (2,695 words) - 14:39, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,883 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,607 words) - 14:29, 13 December 2023
- ==Cancer Category/Type== Non-small cell lung cancer (NSCLC)12 KB (1,650 words) - 14:21, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,259 words) - 14:18, 13 December 2023
- {{DISPLAYTITLE:Hepatosplenic T-cell lymphoma}} ...ate on 2023-12-07. The original page can be found at [[HAEM4:Hepatosplenic T-cell Lymphoma]].22 KB (3,064 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,355 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== Breast cancer / Fibroepithelial Tumors of the Breast16 KB (2,255 words) - 13:27, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==14 KB (1,944 words) - 14:27, 13 December 2023
- ==Cancer Category/Type== Colorectal cancer13 KB (1,790 words) - 18:29, 5 January 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==16 KB (2,262 words) - 14:40, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (2,044 words) - 10:09, 27 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==14 KB (1,866 words) - 11:58, 13 April 2020
- ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]]. [[File:T(6;9)(p23;q34).png]]19 KB (2,611 words) - 14:17, 13 December 2023
- ...al page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]]. ==Cancer Category / Type==19 KB (2,659 words) - 14:32, 13 December 2023
- ...can be found at [[HAEM4:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]]. ==Cancer Category / Type==18 KB (2,546 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (1,965 words) - 14:30, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,652 words) - 14:34, 13 December 2023
- ...liferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]. ==Cancer Category / Type==18 KB (2,549 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,372 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,651 words) - 14:36, 13 December 2023
- {{DISPLAYTITLE:Indolent T-cell lymphoma of the gastrointestinal tract}} ...template on 2023-12-07. The original page can be found at [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]].20 KB (2,747 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,651 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==17 KB (2,307 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== * [[HAEM4:Mature T- and NK-cell Neoplasms]]19 KB (2,622 words) - 14:21, 13 December 2023
- {{DISPLAYTITLE:Monomorphic epitheliotropic intestinal T-cell lymphoma}} ...iginal page can be found at [[HAEM4:Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]].19 KB (2,721 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==20 KB (2,830 words) - 14:34, 13 December 2023
- ==Cancer Category/Type== *T-cell acute lymphoblastic leukaemia (T-ALL)14 KB (1,939 words) - 18:10, 5 January 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,015 words) - 14:30, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==17 KB (2,350 words) - 13:52, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,722 words) - 14:16, 13 December 2023
- ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]]. ==Cancer Category / Type==21 KB (2,953 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==15 KB (2,067 words) - 14:23, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,639 words) - 14:38, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (2,984 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==25 KB (3,405 words) - 14:26, 13 December 2023
- {{DISPLAYTITLE:Mixed-phenotype acute leukaemia, T/myeloid}} ...iginal page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]].19 KB (2,751 words) - 14:31, 13 December 2023
- UT MD Anderson Cancer Center ==Cancer Category / Type==21 KB (2,945 words) - 14:37, 13 December 2023
- ...al page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==21 KB (2,942 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,703 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,920 words) - 14:35, 13 December 2023
- ...able derived from Akkari et al., 2020 [PMID 32302940] with permission from Cancer Genetics. All percentages are approximate. |t(12;21)(p13;q22); [[ETV6]]-[[RUNX1]]*33 KB (4,848 words) - 10:50, 26 July 2021
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,114 words) - 14:16, 13 December 2023
- {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell ==Cancer Category / Type==23 KB (3,154 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,252 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,077 words) - 14:26, 13 December 2023
- ==Cancer Category/Type== * Angioimmunoblastic T-cell lymphoma20 KB (2,671 words) - 14:44, 10 August 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==19 KB (2,643 words) - 13:51, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,981 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==20 KB (2,857 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==19 KB (2,638 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== Mature T- and NK-cell neoplasms21 KB (2,919 words) - 14:19, 13 December 2023
- {{DISPLAYTITLE:T-large granular lymphocytic leukaemia}} ...the new template on 2023-12-07. The original page can be found at [[HAEM4:T-cell Large Granular Lymphocytic Leukemia]].22 KB (3,037 words) - 14:41, 13 December 2023
- ==Cancer Category/Type== ...scular endothelial growth factor (''VEGF'') (Merdzhanova et al., 2010). In cancer, ''SRSF2'' variants have been implicated in leukemia and myeloid disorders16 KB (2,281 words) - 14:50, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,152 words) - 14:16, 13 December 2023
- .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)23 KB (3,285 words) - 15:49, 13 September 2019
- .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)23 KB (3,285 words) - 16:56, 8 August 2020
- .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)23 KB (3,282 words) - 11:49, 14 June 2019
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,890 words) - 14:33, 13 December 2023
- ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]]. ==Cancer Category / Type==29 KB (4,172 words) - 14:17, 13 December 2023
- ==Cancer Category/Type== Breast Cancer / Epithelial Tumours of the Breast19 KB (2,737 words) - 13:17, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,639 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,967 words) - 14:22, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,936 words) - 14:33, 13 December 2023
- ...e found at [[HAEM4:Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]]. [[File:t(3;3)(q21;q26.2).png|t(3;3)(q21;q26.2)]]25 KB (3,672 words) - 14:17, 13 December 2023
- Victorian Cancer Cytogenetics Service ==Cancer Category / Type==28 KB (3,984 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,785 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,323 words) - 14:33, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,643 words) - 14:36, 13 December 2023
- ==Cancer Category/Type== ...ET2 and WT1 physically interact, suggesting overlapping pathways for these genes in AML (Wang et al., 2015). ''TET2'' mutations increase the response of low26 KB (3,824 words) - 15:01, 12 December 2023
- {{DISPLAYTITLE:Adult T-cell leukaemia/lymphoma}} ...ew template on 2023-12-07. The original page can be found at [[HAEM4:Adult T-cell Leukemia/Lymphoma]].30 KB (4,300 words) - 14:18, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,527 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,361 words) - 14:22, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==24 KB (3,361 words) - 14:22, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==30 KB (4,118 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,680 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==28 KB (3,914 words) - 14:36, 13 December 2023
- ...ed from Kanagal-Shawanna et al., 2018 [PMID 30377088] with permission from Cancer Genetics. ...urvival in a cohort of MDS or AML patients treated with azacitidine. Blood Cancer J 2013;3:e155.[https://www.ncbi.nlm.nih.gov/pubmed/24185502]</ref><ref name38 KB (5,270 words) - 17:10, 30 April 2020
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==29 KB (4,102 words) - 14:17, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,074 words) - 13:28, 29 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==32 KB (4,341 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==40 KB (5,552 words) - 14:34, 13 December 2023
- ==Cancer Category/Type== ===Role in Cancer===20 KB (2,904 words) - 03:02, 13 August 2018
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,703 words) - 14:23, 13 December 2023
- Cancer Metastasis Rev (2014) 33:1109–1124 PMID:[http://www.ncbi.nlm.nih.gov/pubm ...gnature PI3K/AKT and mTOR pathways elevated; high expression of several genes representing targets for immunotherapy including PDCD1, CD247, PDCD1LG2, CT8 KB (1,050 words) - 16:48, 19 August 2016
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,637 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==25 KB (3,458 words) - 14:35, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,137 words) - 10:13, 27 February 2024
- !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence ...linelibrary.wiley.com/doi/10.1002/gcc.22083|journal=Genes, Chromosomes and Cancer|language=en|volume=52|issue=10|pages=873–886|doi=10.1002/gcc.22083|issn=121 KB (3,051 words) - 17:48, 2 May 2024
- ...Table derived from Pugh et al., 2018 [PMID 30393007] with permission from Cancer Genetics. |'''Genes'''17 KB (2,298 words) - 16:42, 22 April 2021
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==26 KB (3,699 words) - 14:26, 13 December 2023
- {{DISPLAYTITLE:Systemic EBV-positive T-cell lymphoma of childhood}} ...023-12-07. The original page can be found at [[HAEM4:Systemic EBV-Positive T-cell Lymphoma of Childhood]].26 KB (3,630 words) - 14:40, 13 December 2023
- ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]32 KB (4,584 words) - 14:16, 13 December 2023
- {{DISPLAYTITLE:Enteropathy-associated T-cell lymphoma}} ...23-12-07. The original page can be found at [[HAEM4:Enteropathy-Associated T-cell Lymphoma]].31 KB (4,371 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==29 KB (4,258 words) - 14:22, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==21 KB (2,978 words) - 13:33, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==29 KB (3,951 words) - 14:37, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==34 KB (4,742 words) - 14:34, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,828 words) - 14:18, 13 December 2023
- ...n 2023-12-07. The original page can be found at [[HAEM4:Angioimmunoblastic T-cell Lymphoma]]. ==Cancer Category / Type==34 KB (4,909 words) - 14:35, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==34 KB (4,782 words) - 16:37, 20 December 2023
- ==Cancer Category/Type== [[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]22 KB (3,117 words) - 15:04, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==27 KB (3,735 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==31 KB (4,299 words) - 14:17, 13 December 2023
- ==Cancer Category/Type== [[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]24 KB (3,522 words) - 15:04, 12 December 2023
- ...be found at [[HAEM4:Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]]. ==Cancer Category / Type==30 KB (4,324 words) - 14:16, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==23 KB (3,102 words) - 13:55, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==28 KB (3,970 words) - 14:19, 13 December 2023
- {{DISPLAYTITLE:Early T-precursor lymphoblastic leukaemia / lymphoma}} ...ew template on 2023-12-07. The original page can be found at [[HAEM4:Early T-Cell Precursor Lymphoblastic Leukemia]].25 KB (3,503 words) - 14:24, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==33 KB (4,726 words) - 14:22, 13 December 2023
- ...somal abnormalities identified by standard methods has led to discovery of genes, and gene function and dysfunction. This knowledge has led to improved ther ..., et al.; Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute. Karyotype is an independent prognostic factor in adult59 KB (8,449 words) - 19:11, 27 July 2016
- ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]42 KB (5,916 words) - 14:32, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==40 KB (5,683 words) - 14:36, 13 December 2023
- ==Cancer Category/Type== * Prostate cancer38 KB (5,062 words) - 12:33, 10 August 2018
- ...Table derived from Chun et al., 2018 [PMID 30554732] with permission from Cancer Genetics. |'''Relevant Genes'''40 KB (5,707 words) - 22:25, 7 November 2020
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==34 KB (4,834 words) - 14:25, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==31 KB (4,295 words) - 14:22, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==39 KB (5,484 words) - 14:43, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==48 KB (6,794 words) - 14:27, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==56 KB (7,988 words) - 14:24, 13 December 2023
- The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas ==Cancer Category / Type==41 KB (5,923 words) - 14:31, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==42 KB (6,120 words) - 14:27, 13 December 2023
- ==Cancer Category/Type== '''Natural Killer/T-cell Lymphoma'''36 KB (5,335 words) - 14:18, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==55 KB (7,745 words) - 14:29, 13 December 2023
- ..., MS, Neuropathology Fellow Houston Methodist/Texas Children’s/MD Anderson Cancer Center ==Cancer Category/Type==36 KB (5,058 words) - 13:49, 25 February 2024
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==52 KB (7,572 words) - 14:28, 13 December 2023
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==31 KB (4,325 words) - 13:55, 25 February 2024
- ::T-cell and NK/T-cell lymphomas ::Mismatch repair cancer syndrome38 KB (3,868 words) - 13:56, 12 December 2023
- ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]64 KB (9,095 words) - 14:16, 13 December 2023
- ...Table derived from Liu et al., 2020 [PMID 32434132] with permission from Cancer Genetics. ...ehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer|url=https://pubmed.ncbi.nlm.nih.gov/23083876|journal=The Journal of Urology42 KB (5,820 words) - 13:40, 19 May 2021
- |Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center |T. Niroshi Senaratne, UCLA61 KB (7,864 words) - 16:23, 16 April 2024
- ...ist is based on the 2016 [http://cancer.sanger.ac.uk/census/ Sanger Centre Cancer Gene Census]. | [[ABL1]] || 9q34.1 || [[CML]],[[ALL]],[[T-ALL]] || [[BCR]],[[ETV6]],[[NUP214]]38 KB (4,038 words) - 18:34, 17 July 2016
- The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas ==Cancer Category / Type==80 KB (11,414 words) - 14:36, 13 December 2023
- ...://pubmed.ncbi.nlm.nih.gov/32203924/ PMID: 32203924]] with permission from Cancer Genetics. ...ilocytic astrocytomas|url=https://pubmed.ncbi.nlm.nih.gov/18974108|journal=Cancer Research|volume=68|issue=21|pages=8673–8677|doi=10.1158/0008-5472.CAN-08-103 KB (13,991 words) - 17:05, 20 April 2021